<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9710582" created="22/06/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9710582</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">The <term id="T1" lex="small_GTP-binding_protein_Rho" sem="Protein_molecule">small <term id="T2" lex="GTP" sem="Nucleotide">GTP</term>-binding protein <term id="T3" lex="Rho" sem="Protein_molecule">Rho</term></term> potentiates <term id="T5" lex="AP-1" sem="Protein_molecule">AP-1</term> <term id="A7" sem="Other">transcription</term> in <term id="T6" lex="T_cell" sem="Cell_natural">T cells</term>.</sentence>
<event id="E1">
<type class="Positive_regulation"/>
<theme idref="E2"/>
<cause idref="T3"/>
<clue>The small GTP-binding protein Rho <clueType>potentiates</clueType> AP-1 transcription in T cells.</clue>
</event>
<event id="E2">
<type class="Positive_regulation"/>
<theme idref="A7"/>
<cause idref="T5"/>
<clue>The small GTP-binding protein Rho potentiates AP-1 transcription <clueLoc>in T cells</clueLoc>.</clue>
<comment>NO CLUETYPE</comment></event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term id="T7" lex="Rho" sem="Protein_molecule">Rho</term> family of <term id="T8" lex="small_GTP-binding_protein" sem="Protein_family_or_group">small <term id="T9" lex="GTP" sem="Nucleotide">GTP</term>-binding proteins</term> is involved in the regulation of <term id="T10" lex="cytoskeletal_structure" sem="Other">cytoskeletal structure</term>, <term id="T11" lex="gene_transcription" sem="Other">gene transcription</term>, <term id="T12" lex="specific_cell_fate_development" sem="Other">specific cell fate development</term>, and <term id="A1" sem="Other">transformation</term>.</sentence>
<event KT="Fact" id="E3">
<type class="Regulation"/>
<theme idref="T10"/>
<cause idref="T7"/>
<clue>The Rho family of small GTP-binding proteins is <clueType>involved in the regulation</clueType> <linkTheme>of</linkTheme> cytoskeletal structure, gene transcription, specific cell fate development, and transformation.</clue>
</event>
<event KT="Fact" id="E4">
<type class="Regulation"/>
<theme idref="T11"/>
<cause idref="T7"/>
<clue>The Rho family of small GTP-binding proteins is <clueType>involved in the regulation</clueType> <linkTheme>of</linkTheme> cytoskeletal structure, gene transcription, specific cell fate development, and transformation.</clue>
</event>
<event KT="Fact" id="E5">
<type class="Regulation"/>
<theme idref="T12"/>
<cause idref="T7"/>
<clue>The Rho family of small GTP-binding proteins is <clueType>involved in the regulation</clueType> <linkTheme>of</linkTheme> cytoskeletal structure, gene transcription, specific cell fate development, and transformation.</clue>
</event>
<event KT="Fact" id="E6">
<type class="Regulation"/>
<theme idref="A1"/>
<cause idref="T7"/>
<clue>The Rho family of small GTP-binding proteins is <clueType>involved in the regulation</clueType> <linkTheme>of</linkTheme> cytoskeletal structure, gene transcription, specific cell fate development, and transformation.</clue>
</event>
<sentence id="S3">We demonstrate in this report that overexpression of an <term id="A2" sem="Protein_molecule">activated form of <term id="T13" lex="Rho" sem="Protein_molecule">Rho</term></term> enhances <term id="T14" lex="AP-1" sem="Protein_molecule">AP-1</term> activity in <term id="T15" lex="Jurkat_T_cell" sem="Cell_cultured">Jurkat T cells</term> in the presence of <term id="T16" lex="phorbol_myristate_acetate" sem="Organic_compound_other">phorbol myristate acetate</term> (<term id="T17" lex="PMA" sem="Organic_compound_other">PMA</term>), but activated <term id="T18" lex="Rho" sem="Protein_molecule">Rho</term> (<term id="T19" lex="V14Rho" sem="Protein_molecule">V14Rho</term>) has little or no effect on <term id="T20" lex="NFAT" sem="Protein_family_or_group">NFAT</term>, <term id="T21" lex="Oct-1" sem="Protein_molecule">Oct-1</term>, and <term id="T22" lex="NF-kappaB_enhancer_element" sem="DNA_domain_or_region"><term id="T23" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> enhancer element</term> activities under similar conditions.</sentence>
<event KT="Other" id="E7">
<type class="Gene_expression"/>
<theme idref="A2"/>
<clue>We demonstrate in this report that <clueType>overexpression</clueType> <linkTheme>of</linkTheme> an activated form of Rho enhances AP-1 activity in Jurkat T cells in the presence of phorbol myristate acetate (PMA), but activated Rho (V14Rho) has little or no effect on NFAT, Oct-1, and NF-kappaB enhancer element activities under similar conditions.</clue>
<comment>TPS: A2</comment></event>
<event KT="Other" id="E33">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<clue>We demonstrate in this report that <clueType>overexpression</clueType> of an activated form of Rho enhances AP-1 activity in Jurkat T cells in the presence of phorbol myristate acetate (PMA), but activated Rho (V14Rho) has little or no effect on NFAT, Oct-1, and NF-kappaB enhancer element activities under similar conditions.</clue>
</event>
<event KT="Analysis" id="E8">
<type class="Positive_regulation"/>
<theme idref="T14"/>
<cause idref="E33"/>
<cause idref="T17"/>
<clue>We <clueKT>demonstrate</clueKT> in this report that overexpression of an activated form of Rho <clueType>enhances</clueType> AP-1 activity <clueLoc>in Jurkat T cells</clueLoc> <linkCause>in the presence of</linkCause> phorbol myristate acetate (PMA), but activated Rho (V14Rho) has little or no effect on NFAT, Oct-1, and NF-kappaB enhancer element activities under similar conditions.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E9">
<type class="Regulation"/>
<theme idref="T20"/>
<cause idref="T19"/>
<clue>We <clueKT>demonstrate</clueKT> in this report that overexpression of an activated form of Rho enhances AP-1 activity in Jurkat T cells in the presence of phorbol myristate acetate (PMA), but activated Rho (V14Rho) has little or <cluePolarity>no</cluePolarity> <clueType>effect</clueType> <linkTheme>on</linkTheme> NFAT, Oct-1, and NF-kappaB enhancer element activities under similar conditions.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E10">
<type class="Regulation"/>
<theme idref="T21"/>
<cause idref="T19"/>
<clue>We <clueKT>demonstrate</clueKT> in this report that overexpression of an activated form of Rho enhances AP-1 activity in Jurkat T cells in the presence of phorbol myristate acetate (PMA), but activated Rho (V14Rho) has little or <cluePolarity>no</cluePolarity> <clueType>effect</clueType> <linkTheme>on</linkTheme> NFAT, Oct-1, and NF-kappaB enhancer element activities under similar conditions.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E11">
<type class="Regulation"/>
<theme idref="T23"/>
<cause idref="T19"/>
<clue>We <clueKT>demonstrate</clueKT> in this report that overexpression of an activated form of Rho enhances AP-1 activity in Jurkat T cells in the presence of phorbol myristate acetate (PMA), but activated Rho (V14Rho) has little or <cluePolarity>no</cluePolarity> <clueType>effect</clueType> <linkTheme>on</linkTheme> NFAT, Oct-1, and NF-kappaB enhancer element activities under similar conditions.</clue>
</event>
<sentence id="S4">Overexpression of a <term id="T24" lex="V14Rho_construct" sem="DNA_molecule"><term id="T25" lex="V14Rho" sem="Protein_molecule">V14Rho</term> construct</term> incapable of <term id="T26" lex="membrane_localization" sem="Other">membrane localization</term> (<term id="T27" lex="CAAX_deleted" sem="DNA_molecule"><term id="A3" sem="Polynucleotide">CAAX</term> deleted</term>) abolishes <term id="T28" lex="PMA" sem="Organic_compound_other">PMA</term>-induced <term id="T29" lex="AP-1_transcriptional_activation" sem="Other"><term id="T30" lex="AP-1" sem="Protein_molecule">AP-1</term> transcriptional activation</term>.</sentence>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E12">
<type class="Localization"/>
<theme idref="T24"/>
<clue>Overexpression of a V14Rho construct <cluePolarity>in</cluePolarity><clueKT><clueCL>capable</clueCL></clueKT> of <clueLoc>membrane</clueLoc> <clueType>localization</clueType> (CAAX deleted) abolishes PMA-induced AP-1 transcriptional activation.</clue>
</event>
<event id="E13">
<type class="Gene_expression"/>
<theme idref="T25"/>
<clue><clueType>Overexpression</clueType> <linkTheme>of</linkTheme> a V14Rho construct incapable of membrane localization (CAAX deleted) abolishes PMA-induced AP-1 transcriptional activation.</clue>
</event>
<event id="E34">
<type class="Positive_regulation"/>
<theme idref="E13"/>
<clue><clueType>Overexpression</clueType> of a V14Rho construct incapable of membrane localization (CAAX deleted) abolishes PMA-induced AP-1 transcriptional activation.</clue>
</event>
<event id="E14">
<type class="Negative_regulation"/>
<theme idref="E15"/>
<cause idref="E34"/>
<clue>Overexpression of a V14Rho construct incapable of membrane localization (CAAX deleted) <clueType>abolishes</clueType> PMA-induced AP-1 transcriptional activation.</clue>
</event>
<event KT="Other" id="E15">
<type class="Positive_regulation"/>
<theme idref="T30"/>
<cause idref="T28"/>
<clue>Overexpression of a V14Rho construct incapable of membrane localization (CAAX deleted) abolishes PMA<linkCause>-induced</linkCause> AP-1 <clueType>transcriptional activation</clueType>.</clue>
</event>
<sentence id="S5">The effect of <term id="T31" lex="Rho" sem="Protein_molecule">Rho</term> on <term id="T32" lex="AP-1" sem="Protein_molecule">AP-1</term> is independent of the <term id="T33" lex="mitogen-activated_protein_kinase_pathway" sem="Other"><term id="T34" lex="mitogen-activated_protein_kinase" sem="Protein_family_or_group">mitogen-activated protein kinase</term> pathway</term>, as a <term id="T35" lex="dominant-negative_MEK" sem="Protein_molecule">dominant-negative <term id="T36" lex="MEK" sem="Protein_molecule">MEK</term></term> and a <term id="T37" lex="MEK_inhibitor" sem="Organic_compound_other"><term id="T38" lex="MEK" sem="Protein_molecule">MEK</term> inhibitor</term> (<term id="T39" lex="PD98059" sem="Organic_compound_other">PD98059</term>) did not affect <term id="T41" lex="Rho" sem="Protein_molecule">Rho</term>-induced <term id="T420" sem="Other"><term id="T42" lex="AP-1" sem="Protein_molecule">AP-1</term> activity</term>.</sentence>
<event id="E18">
<type class="Regulation"/>
<theme idref="T32"/>
<cause idref="T31"/>
<clue>The <clueType>effect</clueType> <linkCause>of</linkCause> Rho <linkTheme>on</linkTheme> AP-1 is independent of the mitogen-activated protein kinase pathway, as a dominant-negative MEK and a MEK inhibitor (PD98059) did not affect Rho-induced AP-1 activity.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E19">
<type class="Regulation"/>
<theme idref="E18"/>
<cause idref="T34"/>
<clue>The effect of Rho on AP-1 is <clueType><cluePolarity>independent</cluePolarity></clueType> <linkCause>of</linkCause> the mitogen-activated protein kinase pathway, as a dominant-negative MEK and a MEK inhibitor (PD98059) did not affect Rho-induced AP-1 activity.</clue>
</event>
<event id="E20">
<type class="Positive_regulation"/>
<theme idref="T42"/>
<cause idref="T41"/>
<clue>The effect of Rho on AP-1 is independent of the mitogen-activated protein kinase pathway, as a dominant-negative MEK and a MEK inhibitor (PD98059) did not affect Rho-<clueType>induced</clueType> AP-1 activity.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E21">
<type class="Regulation"/>
<theme idref="E20"/>
<cause idref="T36"/>
<clue>The effect of Rho on AP-1 is independent of the mitogen-activated protein kinase pathway, as a dominant-negative MEK and a MEK inhibitor (PD98059) did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> Rho-induced AP-1 activity.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E22">
<type class="Regulation"/>
<theme idref="E20"/>
<cause idref="T39"/>
<clue>The effect of Rho on AP-1 is independent of the mitogen-activated protein kinase pathway, as a dominant-negative MEK and a <corefCause>MEK inhibitor</corefCause> (PD98059) did <cluePolarity>not</cluePolarity> <clueType>affect</clueType> Rho-induced AP-1 activity.</clue>
</event>
<sentence id="S6"><term id="T43" lex="V14Rho" sem="Protein_molecule">V14Rho</term> binds strongly to <term id="T44" lex="protein_kinase_Calpha" sem="Protein_molecule">protein kinase Calpha</term> (<term id="T45" lex="PKCalpha" sem="Protein_molecule">PKCalpha</term>) in vivo; however, deletion of the <term id="T46" lex="CAAX_site" sem="DNA_domain_or_region">CAAX site</term> on <term id="T47" lex="V14Rho" sem="Protein_molecule">V14Rho</term> severely diminished this association.</sentence>
<event Manner="High" id="E23">
<type class="Binding"/>
<theme idref="T43"/>
<theme idref="T45"/>
<clue>V14Rho <clueType>binds</clueType> <clueManner>strongly</clueManner> <linkTheme>to</linkTheme> protein kinase Calpha (PKCalpha) in vivo; however, deletion of the CAAX site on V14Rho severely diminished this association.</clue>
</event>
<event KT="Method" id="E24">
<type class="Mutagenesis"/>
<theme idref="T46"/>
<theme idref="T47"/>
<clue>V14Rho binds strongly to protein kinase Calpha (PKCalpha) in vivo; however, <clueType>deletion</clueType> <linkTheme>of</linkTheme> the CAAX site <linkTheme>on</linkTheme> V14Rho severely diminished this association.</clue>
<comment>TPS: A30; ARTIFICIAL</comment></event>
<event Manner="High" id="E25">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="E24"/>
<clue>V14Rho binds strongly to protein kinase Calpha (PKCalpha) in vivo; however, deletion of the CAAX site on V14Rho <clueManner>severely</clueManner> <clueType>diminished</clueType> <corefTheme>this association</corefTheme>.</clue>
</event>
<sentence id="S7">Evidence for a role for <term id="T48" lex="PKCalpha" sem="Protein_molecule">PKCalpha</term> as an effector of <term id="T49" lex="Rho" sem="Protein_molecule">Rho</term> was obtained by the observation that coexpression of the <term id="A6" sem="Protein_domain_or_region"><term id="T50" lex="N-terminal_domain" sem="Protein_domain_or_region">N-terminal domain</term> of <term id="T51" lex="PKCalpha" sem="Protein_molecule">PKCalpha</term></term> blocked the effects of <term id="A4" sem="Protein_molecule">activated <term id="T52" lex="Rho" sem="Protein_molecule">Rho</term></term> plus <term id="T53" lex="PMA" sem="Organic_compound_other">PMA</term> on <term id="T54" lex="AP-1_transcriptional_activity" sem="Other"><term id="T55" lex="AP-1" sem="Protein_molecule">AP-1</term> transcriptional activity</term>.</sentence>
<event CL="L2" KT="Analysis" id="E26">
<type class="Positive_regulation"/>
<theme idref="T49"/>
<cause idref="T48"/>
<clue><clueKT><clueCL>Evidence</clueCL></clueKT> for a <clueType>role</clueType> <linkCause>for</linkCause> PKCalpha <clueType>as an effector</clueType> <linkTheme>of</linkTheme> Rho was obtained by the observation that coexpression of the N-terminal domain of PKCalpha blocked the effects of activated Rho plus PMA on AP-1 transcriptional activity.</clue>
</event>
<event id="E27">
<type class="Gene_expression"/>
<theme idref="A6"/>
<clue>Evidence for a role for PKCalpha as an effector of Rho was obtained by the observation that <clueType>coexpression</clueType> <linkTheme>of</linkTheme> the N-terminal domain of PKCalpha blocked the effects of activated Rho plus PMA on AP-1 transcriptional activity.</clue>
<comment>TPS: A6</comment></event>
<event id="E28">
<type class="Negative_regulation"/>
<theme idref="E29"/>
<cause idref="E27"/>
<clue>Evidence for a role for PKCalpha as an effector of Rho was obtained by the <clueKT>observation</clueKT> that coexpression of the N-terminal domain of PKCalpha <clueType>blocked</clueType> the effects of activated Rho plus PMA on AP-1 transcriptional activity.</clue>
</event>
<event KT="Other" id="E29">
<type class="Regulation"/>
<theme idref="T55"/>
<cause idref="A4"/>
<cause idref="T53"/>
<clue>Evidence for a role for PKCalpha as an effector of Rho was obtained by the observation that coexpression of the N-terminal domain of PKCalpha blocked the <clueType>effects</clueType> <linkCause>of</linkCause> activated Rho plus PMA <linkTheme>on</linkTheme> AP-1 transcriptional activity.</clue>
</event>
<sentence id="S8">These data suggest that <term id="T56" lex="Rho" sem="Protein_molecule">Rho</term> potentiates <term id="T58" lex="AP-1" sem="Protein_molecule">AP-1</term> <term id="A8" sem="Other">transcription</term> during <term id="T59" lex="T-cell_activation" sem="Other"><term id="A5" sem="Cell_natural">T-cell</term> activation</term>.</sentence>
<event CL="L2" KT="Analysis" id="E30">
<type class="Positive_regulation"/>
<theme idref="E31"/>
<cause idref="T56"/>
<clue>These data <clueKT><clueCL>suggest</clueCL></clueKT> that Rho <clueType>potentiates</clueType> AP-1 transcription <clueTime>during T-cell activation</clueTime>.</clue>
</event>
<event KT="Other" id="E31">
<type class="Positive_regulation"/>
<theme idref="A8"/>
<cause idref="T58"/>
<clue>These data suggest that Rho potentiates AP-1 transcription during T-cell activation.</clue>
<comment>NO CLUETYPE</comment></event>
<event KT="Other" id="E32">
<type class="Physiological_process"/>
<theme idref="A5"/>
<clue>These data suggest that Rho potentiates AP-1 transcription during T-cell <clueType>activation</clueType>.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
